Literature DB >> 18607372

Soothing the seizures of children.

Beat Lutz1, Krisztina Monory.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18607372     DOI： 10.1038/nm0708-721

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  7 in total

1.  Modulation of anticonvulsant effects of cannabinoid compounds by GABA-A receptor agonist in acute pentylenetetrazole model of seizure in rat.

Authors:  Nima Naderi; Leila Ahmad-Molaei; Farzad Aziz Ahari; Fereshteh Motamedi
Journal:  Neurochem Res       Date:  2011-04-23       Impact factor: 3.996

Review 2.  Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention.

Authors:  Mackenzie E Hofmann; Charles J Frazier
Journal:  Exp Neurol       Date:  2011-12-09       Impact factor: 5.330

Review 3.  Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development.

Authors:  Javier Díaz-Alonso; Manuel Guzmán; Ismael Galve-Roperh
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 4.  Cannabinoids for epilepsy.

Authors:  David Gloss; Barbara Vickrey
Journal:  Cochrane Database Syst Rev       Date:  2014-03-05

5.  Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model.

Authors:  Julio Echegoyen; Caren Armstrong; Robert J Morgan; Ivan Soltesz
Journal:  Epilepsy Res       Date:  2009-04-15       Impact factor: 3.045

Review 6.  Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis.

Authors:  Caren Armstrong; Robert J Morgan; Ivan Soltesz
Journal:  Epilepsia       Date:  2009-07-01       Impact factor: 5.864

Review 7.  The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models.

Authors:  Jon Egaña-Huguet; Edgar Soria-Gómez; Pedro Grandes
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.